Rx · Prescription onlyInjected under the skin

Semaglutide + Methylcobalamin + Glycine

Your plan

1 vial · lasts 4 weeks · 0.4–2.5 mg semaglutide, set by your clinician

You'll see the price in your assessment

  • Medication, clinician care and dose adjustments, all in one price.

A licensed clinician on our care team reviews every request and prescribes only when it's clinically appropriate.

FDA status: Compounded medication, not FDA-approved. Its active ingredient, semaglutide, is also in the FDA-approved drugs Ozempic and Wegovy; this compounded version is not one of them.

What it's for

Who it's for

People who prefer the active form of B12 and want glycine in the same weekly injection.

How it's different

Methylcobalamin is B12 the body can use without converting it; the semaglutide is the same as in the other vials.

How it works

Methylcobalamin is an active form of B12 that supports energy production and nerve health. Glycine is an amino acid that promotes sleep and supports muscle recovery. Together with semaglutide, they address appetite (GLP-1), energy (B12), and sleep (glycine).

How to use it and what arrives

1 vial · lasts 4 weeks

Your clinician sets your dose: 0.4–2.5 mg semaglutide · same price at every dose

How
Injected under the skin
How often
Once a week

Good to know

Three vial sizes exist. A larger vial is not a higher dose: follow the units on your label.

What the research shows

Semaglutide is a GLP-1 receptor agonist. Its evidence comes from large randomized trials in adults with obesity, nearly all with the injected 2.4 mg weekly dose.

  1. Weight

    about 15%

    STEP 1: 1,961 adults with obesity or overweight and no diabetes, 68 weeks of weekly injections plus lifestyle advice. Mean weight change was -14.9% with semaglutide and -2.4% with placebo.

    STEP 1, NEJM 2021
  2. Two years

    about 15%

    STEP 5: 304 adults, 104 weeks of weekly 2.4 mg injections with behavioral support. Mean change was -15.2% with semaglutide and -2.6% with placebo.

    STEP 5, Nature Medicine 2022
  3. Heart events

    20% fewer events

    SELECT: 17,604 adults aged 45 and older with overweight or obesity and existing heart disease but no diabetes, followed about 40 months. Major cardiovascular events were 6.5% on 2.4 mg weekly and 8.0% on placebo (hazard ratio 0.80).

    SELECT, NEJM 2023

Trial results are for the injected 2.4 mg weekly product at the dose studied. They are averages, not predictions for one person. Compounded versions were not studied in these trials, and no trial has tested the sublingual (dissolve-under-the-tongue) form. The oral trial OASIS 4 (NEJM 2025, doi 10.1056/NEJMoa2500969) tested a 25 mg tablet swallowed, not a sublingual one.

What this does not say

  • The trials ran 68 to 104 weeks. They do not show what happens over the long term after treatment is stopped.
  • Nausea, diarrhea and vomiting were the most common side effects. In SELECT, 16.6% of people on semaglutide stopped the trial drug for adverse events, against 8.2% on placebo.
  • SELECT and STEP trials were funded by the manufacturer; the figures are for brand-name semaglutide in trial conditions.

Sources

  1. Semaglutide for weight loss (STEP 1): once-weekly GLP-1 resulted in mean 15% weight loss over 68 weeks. NEJM, 2021 (Wilding JPH et al.)
  2. L-carnitine supplementation improves energy metabolism and exercise performance in metabolic studies. Nutrients, 2021 (Malaguarnera M)
Read the full research

Safety

FDA status: Compounded medication, not FDA-approved. Its active ingredient, semaglutide, is also in the FDA-approved drugs Ozempic and Wegovy; this compounded version is not one of them.

Side effects and precautions

  • Semaglutide plus additives carries the safety profile of semaglutide itself: nausea, vomiting, diarrhea, constipation, reduced appetite, fatigue, and injection-site reactions are common in early weeks.
  • The additives (L-carnitine, methylcobalamin, glycine) are generally well-tolerated.
  • Not for pregnancy or breastfeeding, or with active pancreatitis.

Get care right away

  • Stop and seek care for severe abdominal pain, allergic reactions, or signs of pancreatitis.

When it isn't prescribed

  • Do not use with medullary thyroid carcinoma history or MEN 2.

Tell your clinician about all medications, diabetes drugs, and any kidney or pancreatic disease.

Questions

Why combine semaglutide with B12 and glycine?

Weight loss often brings early fatigue and sleep changes. B12 supports energy production; glycine improves sleep. The combination helps you feel better while losing weight. If your energy and sleep normalize, your clinician may adjust doses.

Do I need all three additives?

Not necessarily. Your clinician will suggest the combination that matches your needs. If fatigue is your main concern, B12 and L-carnitine help. If sleep is the issue, glycine is the focus. You can change your combination over time.

Are additives safe long-term?

Yes. B12, glycine, and L-carnitine are natural compounds your body uses daily. They are safe at the doses used here, even for years of use. Your clinician monitors you at regular check-ins.

What if additives don't help?

Some people feel a difference immediately; others take weeks. If you don't notice energy or sleep improvements after 4–6 weeks, your clinician may adjust doses or try a different additive combination.

Can I combine with other supplements?

Tell your clinician about all supplements you take. Most are safe with semaglutide, but some interactions require monitoring or timing adjustments.

Still have a question? Message our team

Ready to start with Semaglutide + Methylcobalamin + Glycine?

  • Free shipping on every order
  • No membership fee
  • Same price at every dose
  • HSA and FSA accepted

More options in this area